Albert V, Arnet I, Gudka S. Comment on patient adherence to novel oral anticoagulants (NOACs) for the treatment of atrial fibrillation and occurrence of associated bleeding events: A systematic review and meta-analysis. Curr Vasc Pharmacol 2019; 17: 350-1.
Shehab A, Bhagavathula AS, Abebe TB, et al. Patient adherence to novel oral anticoagulants (NOACs) for the treatment of atrial fibrillation and occurrence of associated bleeding events: A systematic review and meta-analysis. Curr Vasc Pharmacol 2019; 17: 341-9.
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: Terminology and definitions. Value Health 2008; 11: 44-7.
Karve S, Cleves MA, Helm M, et al. Good and poor adherence: Optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009; 25: 2303-10.
Woltmann EM, Valenstein M, Welsh DE, et al. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychol Serv 2007; 58: 864-7.
Lehmann A, Aslani P, Ahmed R, et al. Assessing medication adherence: Options to consider. Int J Clin Pharm 2014; 36: 55-69.
Raebel MA, Schmittdiel J, Karter AJ, et al. Standardizing terminology and definition of medication adherence and persistence in research employing electronic databases. Med Care 2013; 51: 11-21.
Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012; 73: 691-705.
Gorst‐Rasmussen A, Skjøth F, Larsen TB, et al. Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: A nationwide cohort study. J Thromb Haemost 2015; 13: 495-504.
Hanemaaijer S, Sodihardjo F, Horikx A, et al. Trends in antithrombotic drug use and adherence to non-vitamin K oral anticoagulants in the Netherlands. Int J Clin Pharm 2015; 37: 1128-35.